Rishabha Malviya Malviya (Rishabha Malviya)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 38

Top Topics

Top Venues

Current pharmaceutical design

Current pharmaceutical biotechnology

Current drug targets

Dermatologic therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Shristy Verma, Pramod Sharma, Rishabha Malviya Malviya, Sanjita Das
Advances in Aerogels Formulations for Pulmonary Targeted Delivery of Therapeutic Agents: Safety, Efficacy and Regulatory Aspects. Current pharmaceutical biotechnology (2024)
Babita Gupta, Rishabha Malviya Malviya, Saurabh Srivastava, Irfan Ahmad, Safia Obaidur Rab, Prerna Uniyal
Construction, Features and Regulatory Aspects of Organ-Chip for Drug Delivery Applications: Advances and Prospective. Current pharmaceutical design (2024)
Shivam Rajput, Pramod Kumar Sharma, Rishabha Malviya Malviya
Biomarkers and Treatment Strategies for Breast Cancer Recurrence. Current drug targets 24 (15) (2024)
Sonali Sundram, Neerupma Dhiman, Rishabha Malviya Malviya, Rajendra Awasthi
Synthesis of Novel Acrylamide Graft Copolymer of Acacia nilotica Gum for the Stabilization of Melatonin Nanoparticles for Improved Therapeutic Effect: Optimization Using (3) 2 Factorial Design. Assay and drug development technologies (2024)
Shivam Rajput, Pramod Kumar Sharma, Rishabha Malviya Malviya
Biomarkers and Treatment Strategies for Breast Cancer Recurrence. Current drug targets 24 (15) (2024)
Shivam Rajput, Rishabha Malviya Malviya, Prerna Uniyal
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells. Current pharmaceutical design 30 (11) (2024)
Shristy Verma, Rishabha Malviya Malviya, Sathvik Belagodu Sridhar
Toxicity Concern for the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease. Central nervous system agents in medicinal chemistry (2024)
Aayush Prakash, Rishabha Malviya Malviya, Deependra Pratap Singh
Transformative Potential and Healthcare Applications of 3D Printing. Current pharmaceutical design (2024)
Shivam Rajput, Rishabha Malviya Malviya, Prerna Uniyal
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells. Current pharmaceutical design 30 (11) (2024)
Rishav Sharma, Rishabha Malviya Malviya, Saurabh Srivastava, Irfan Ahmad, Safia Obaidur Rab, Prerna Uniyal
Targeted Treatment Strategies for Mitochondria Dysfunction: Correlation with Neurological Disorders. Current drug targets (2024)
Shivam Rajput, Rishabha Malviya Malviya, Prerna Uniyal
Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells. Current pharmaceutical design (2024)
Babita Gupta, Rishabha Malviya Malviya, Saurabh Srivastava, Irfan Ahmad, Safia Obaidur Rab, Deependra Pratap Singh
3D Printed Nanosensors for Cancer Diagnosis: Advances and Future Perspective. Current pharmaceutical design (2024)
Shristy Verma, Pramod Kumar Sharma, Rishabha Malviya Malviya, Sanjita Das
Advances in Aerogels Formulations for Pulmonary Targeted Delivery of Therapeutic Agents: Safety, Efficacy and Regulatory Aspects. Current pharmaceutical biotechnology 25 (15) (2024)
Shristy Verma, Pramod Kumar Sharma, Rishabha Malviya Malviya
Advances in Aerosol Formulation for Targeted Delivery of Therapeutic Agents from Nose to Brain. Current drug delivery (2024)
Babita Gupta, Pramod Kumar Sharma, Rishabha Malviya Malviya
Carbon Nanotubes for Targeted Therapy: Safety, Efficacy, Feasibility and Regulatory Aspects. Current pharmaceutical design 30 (2) (2024)
Shristy Verma, Rishabha Malviya Malviya, Prerna Uniyal
Survival of Patients with Primary Brain Tumor: A Data Analysis of 10 Years. Current pharmaceutical design 30 (15) (2024)
Suraj Kumar, Rishabha Malviya Malviya, Prerna Uniyal, Saurabh Srivastava, Sathvik Belagodu Sridhar, Safia Obaidur Rab, Bhupinder Singh
Plant Fiber Composites for Biomedical Applications: Advances and Prospective. Current pharmaceutical biotechnology (2024)
Shristy Verma, Rishabha Malviya Malviya, Prerna Uniyal
Survival of Patients with Primary Brain Tumor: A Data Analysis of 10 Years. Current pharmaceutical design 30 (15) (2024)
Babita Gupta, Pramod Kumar Sharma, Rishabha Malviya Malviya
Carbon Nanotubes for Targeted Therapy: Safety, Efficacy, Feasibility and Regulatory Aspects. Current pharmaceutical design (2024)
Shristy Verma, Rishabha Malviya Malviya, Saurabh Srivastava, Irfan Ahmad, Bhupinder Singh, Rasha Almontasheri, Prerna Uniyal
Shape Dependent Therapeutic Potential of Nanoparticulate System: Advance Approach for Drug Delivery. Current pharmaceutical design (2024)
Babita Gupta, Pramod Kumar Sharma, Rishabha Malviya Malviya
Carbon Nanotubes for Targeted Therapy: Safety, Efficacy, Feasibility and Regulatory Aspects. Current pharmaceutical design 30 (2) (2024)
Suraj Kumar, Rishabha Malviya Malviya, Prerna Uniyal
Vaccine for Targeted Therapy of Lung Cancer: Advances and Developments. Current drug targets (2024)
Shristy Verma, Rishabha Malviya Malviya, Prerna Uniyal
Survival of Patients with Primary Brain Tumor: A Data Analysis of 10 Years. Current pharmaceutical design (2024)
Priyanshi Goyal, Rishabha Malviya Malviya
Developments in Stem Cell Therapy by Utilizing Artificial Intelligence. Current pharmaceutical design (2023)
Shivam Rajput, Rishabha Malviya Malviya, Shiv Bahadur, Dinesh Puri
Recent Updates on the Development of Therapeutics for the Targeted Treatment of Alzheimer's Disease. Current pharmaceutical design (2023)
Deepika Yadav, Pramod Kumar Sharma, Rishabha Malviya Malviya, Prem Shankar Mishra, Amareswarapu V Surendra, Gsn Koteswara Rao, Budha Roja Rani
Stimuli-Responsive Biomaterials for Tissue Engineering Applications. Current pharmaceutical biotechnology (2023)
Priyanshi Goyal, Rishabha Malviya Malviya
Advancement in Polymer-Based Carrier for DNA Vaccine. Current pharmaceutical design (2023)
Rishav Sharma, Rishabha Malviya Malviya
Cancer Stem Cells in Carcinogenesis and Potential Role in Pancreatic Cancer. Current stem cell research & therapy (2023)
Shivam Rajput, Pramod Kumar Sharma, Rishabha Malviya Malviya
Utilization of Herbal Components as Insecticidal and Repellent Effects. Recent advances in food, nutrition & agriculture (2023)
Priyanshi Goyal, Rishabha Malviya Malviya
Challenges and opportunities of big data analytics in healthcare. Health care science 2 (5) (2023)
Priyanshi Goyal, Rishabha Malviya Malviya
Stem Cell Therapy for the Management of Type 1 Diabetes: Advances and Perspectives. Endocrine, metabolic & immune disorders drug targets (2023)
Anmol Saxena, Rishabha Malviya Malviya
3D Printable Drug Delivery Systems: Next-generation Healthcare Technology and Regulatory Aspects. Current pharmaceutical design (2023)
Priyanshi Goyal, Rishabha Malviya Malviya
Challenges and opportunities of big data analytics in healthcare. Health care science 2 (5) (2023)
Deepika Yadav, Rishabha Malviya Malviya
Vector-Mediated Delivery of Transgenes and RNA Interference-Based Gene Silencing Sequences to Astrocytes for Disease Management: Advances and Prospectives. Current gene therapy (2023)
Shivkanya Fuloria, Vetriselvan Subramaniyan, Sundram Karupiah, Usha Kumari, Kathiresan Sathasivam, Dhanalekshmi Unnikrishnan Meenakshi, Yuan Seng Wu, Mahendran Sekar, Nitin Chitranshi, Rishabha Malviya Malviya, Kalvatala Sudhakar, Sakshi Bajaj, Neeraj Kumar Fuloria
Comprehensive Review of Methodology to Detect Reactive Oxygen Species (ROS) in Mammalian Species and Establish Its Relationship with Antioxidants and Cancer. Antioxidants (Basel, Switzerland) 10 (1) (2021)
Rishabha Malviya Malviya, Rajendra Awasthi, Pramod Kumar Sharma, Susheel Kumar Dubey
Stabilization of Etoricoxib Nanosuspension Using Acacia chundra Gum and Copolymers: Preparation, Characterization, and In Vitro Cytotoxic Study. Assay and drug development technologies 19 (5) (2021)
Geetanjali Singh, Pramod Kumar Sharma, Rishabha Malviya Malviya, Rajendra Awasthi
Novel corona virus disease (COVID-19) and ophthalmic manifestations: Clinical evidences. Dermatologic therapy 33 (6) (2020)
Akanksha Sharma, Rishabha Malviya Malviya, Vinod Kumar, Ramji Gupta, Rajendra Awasthi
Severity and risk of COVID-19 in cancer patients: An evidence-based learning. Dermatologic therapy 33 (5) (2020)